Foghorn Therapeutics Inc. (NASDAQ: FHTX) reported Q1 EPS of ($0.59), $0.03 better than the analyst estimate of ($0.62). Revenue for the quarter came in at $5.1 million versus the consensus estimate of $6.86 million.

For earnings history and earnings-related data on Foghorn Therapeutics Inc. (FHTX) click here.